Atrial fibrillation in patients with COVID-19. Usefulness of the CHA₂DS₂-VASc score: an analysis of the international HOPE COVID-19 registry.

ABSTRACT:

Introduction and objectives

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2. Atrial fibrillation (AF) is common in acute situations, where it is associated with more complications and higher mortality.

Methods

Analysis of the international HOPE registry (NCT04334291). The objective was to assess the prognostic information of AF in COVID-19 patients. A multivariate analysis and propensity score matching were performed to assess the relationship between AF and mortality. We also evaluated the impact on mortality and embolic events of the CHA₂DS₂-VASc score in these patients.

Results

Among 6217 patients enrolled in the HOPE registry, 250 had AF (4.5%). AF patients had a higher prevalence of cardiovasc

SUBMITTER: Uribarri A 

PROVIDER: S-EPMC7836821 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature